Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Young athletes are being recruited to plug a staff shortage in Japan’s nursing homes. The results are reshaping elder care. By Chang W. Lee, Javier C. Hernández and Hisako Ueno Pablo on TKO’s rise and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results